Emory Hsu, MD
Endocrinology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 21
- 5 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
21 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hsu’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
21 of 21 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A162690 · Current
Licensed to practise in California · since 2019 · expires 2027-05-31 · Vanderbilt University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$19,604
Medicare paid this office $19,604 for 209 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 91 | $7,431 | $69 |
| New patient visit (45+ min) | 62 | $6,628 | $107 |
| Short return visit (20+ min) | 43 | $2,263 | $45 |
| Telephone medical discussion with physician, 21-30 minutes | 20 | $1,886 | $82 |
Who their Medicare patients are
209 Original Medicare patients in 2024. Average age 75 · Under 65 11% · 85 and older 21% · Women 74% · Also on Medicaid 84% · Health risk score 1.37. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 75% · Diabetes 37% · Chronic kidney disease 22% · Depression 15% · Coronary heart disease 13% · Heart failure 13% · Cancer 13% · COPD 11% · Atrial fibrillation 11% · Dementia 11% · Stroke 11%.
The office billed $171,289, Medicare allowed $29,506 and paid $19,604; for 267 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 209 | 267 | 75 | 1.37 | $171,289 | $19,604 |
| 2023 | 205 | 311 | 74 | 1.60 | $172,634 | $19,390 |
| 2022 | 155 | 223 | 72 | 1.38 | $115,086 | $13,276 |
| 2021 | 185 | 287 | 72 | 1.73 | $125,107 | $19,565 |
| 2020 | 140 | 213 | 71 | 1.76 | $89,508 | $9,935 |
| 2019 | 63 | 77 | 72 | 1.67 | $39,110 | $4,952 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 88 | $7,424 | $75 |
| Short return visit (20+ min) | 91 | $4,836 | $43 |
| New patient visit (45+ min) | 29 | $3,255 | $112 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $2,394 | $46 |
2022: 5 services
| Return visit (30+ min) | 73 | $6,674 | $73 |
| Short return visit (20+ min) | 59 | $3,808 | $59 |
| Telephone medical discussion with physician, 11-20 minutes | 23 | $1,155 | $44 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $723 | $52 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $265 | $19 |
2021: 6 services
| Telephone medical discussion with physician, 11-20 minutes | 102 | $6,558 | $52 |
| Return visit (30+ min) | 40 | $4,239 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $2,972 | $74 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 27 | $2,963 | $106 |
| Short return visit (20+ min) | 21 | $1,136 | $54 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,013 | $78 |
2020: 5 services
| Telephone medical discussion with physician, 21-30 minutes | 47 | $3,557 | $68 |
| Telephone medical discussion with physician, 11-20 minutes | 44 | $2,143 | $42 |
| Return visit (30+ min) | 30 | $1,585 | $47 |
| Short return visit (20+ min) | 34 | $773 | $21 |
| Telephone medical discussion with physician, 5-10 minutes | 17 | $376 | $21 |
2019: 3 services
| New patient visit (45+ min) | 16 | $1,724 | $108 |
| Short return visit (20+ min) | 31 | $1,464 | $46 |
| Return visit (30+ min) | 18 | $1,194 | $66 |
Medicaid work
$13,525 in 2024
Medicaid paid $13,525 for 2,993 billed services this clinician did in 2024, up to 99 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 526 | $7,581 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 146 | $4,096 |
| Short return visit (20+ min) | 219 | $1,848 |
| Medication list documented in medical record (COA) | 645 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 454 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 144 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 143 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 555 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 161 | $0 |
| 2024 | 2,993 | 9 | 99 | $13,525 |
| 2023 | 1,048 | 6 | 73 | $6,846 |
| 2022 | 652 | 3 | 46 | $5,832 |
| 2021 | 645 | 5 | 77 | $6,499 |
| 2020 | 108 | 1 | 39 | $924 |
| 2019 | 27 | 1 | 27 | $98 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 346 | $2,702 |
| Short return visit (20+ min) | 423 | $2,135 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 150 | $2,008 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 58 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 30 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 41 | $0 |
2022
| Short return visit (20+ min) | 388 | $2,553 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 113 | $1,941 |
| Return visit (30+ min) | 151 | $1,338 |
2021
| Short return visit (20+ min) | 529 | $5,162 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 31 | $785 |
| IP/OBS CONSLTJ NEW/EST SF 35 | 18 | $230 |
| Return visit (30+ min) | 49 | $193 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 18 | $129 |
2020
| Short return visit (20+ min) | 108 | $924 |
2019
| Short return visit (20+ min) | 27 | $98 |
Drugs they prescribed that Part D paid
$327,078
Pharmacies billed $327,078 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 669) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
411 generic and 226 brand-name prescriptions · $327,078 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tymlos | 58 | $142,734 | $2,461 |
| Teriparatide | 27 | $61,081 | $2,262 |
| Prolia | 41 | $60,328 | $1,471 |
| Testosterone | 17 | $4,586 | $270 |
| Ultra-Fine Mini Pen Needle | 25 | $1,425 | $57 |
See all 14 drugs
| Tymlos | 58 | $142,734 | $2,461 |
| Teriparatide | 27 | $61,081 | $2,262 |
| Prolia | 41 | $60,328 | $1,471 |
| Testosterone | 17 | $4,586 | $270 |
| Ultra-Fine Mini Pen Needle | 25 | $1,425 | $57 |
| Methimazole | 96 | $1,297 | $14 |
| Semglee (Yfgn) | 12 | $1,160 | $97 |
| Levothyroxine | 109 | $1,035 | $9 |
| Hydrocortisone | 28 | $878 | $31 |
| Alendronate | 54 | $462 | $9 |
| Testosterone Cypionate | 12 | $419 | $35 |
| Hydrochlorothiazide | 34 | $107 | $3 |
| Spironolactone | 11 | $76 | $7 |
| Dexamethasone | 18 | $8 | $0 |
Year by year
| 2024 | 669 | 175 | 0% (0) | 34% | $327,078 |
| 2023 | 575 | 168 | 0% (0) | 39% | $361,630 |
| 2022 | 445 | 122 | 0% (0) | 38% | $228,586 |
| 2021 | 511 | 144 | 0% (0) | 37% | $231,144 |
| 2020 | 473 | 96 | 0% (0) | 46% | $223,893 |
| 2019 | 71 | 34 | 0% (0) | None | $35,559 |
| 2015 | 26 | None | 0% (0) | None | $389 |
| 2014 | 130 | 36 | 0% (0) | None | $7,260 |
| 2013 | 47 | 21 | None | None | $2,570 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Tymlos | 34 | $87,311 | $2,568 |
| Prolia | 45 | $74,824 | $1,663 |
| Rybelsus | 11 | $29,631 | $2,694 |
| Basaglar Kwikpen U-100 | 16 | $5,534 | $346 |
| Lantus | 11 | $3,449 | $314 |
| Testosterone | 12 | $3,258 | $272 |
| Novolog | 12 | $2,184 | $182 |
| Semglee (Yfgn) | 11 | $2,096 | $191 |
| Levothyroxine | 67 | $1,787 | $27 |
| Ultra-Fine Mini Pen Needle | 26 | $1,719 | $66 |
| Hydrocortisone | 27 | $1,497 | $55 |
| Methimazole | 66 | $1,343 | $20 |
| Testosterone Cypionate | 14 | $809 | $58 |
| Alendronate | 35 | $555 | $16 |
| Hydrochlorothiazide | 13 | $44 | $3 |
| Dexamethasone | 15 | $7 | $0 |
2022: 10 drugs
| Tymlos | 37 | $96,882 | $2,618 |
| Prolia | 29 | $41,240 | $1,422 |
| Basaglar Kwikpen U-100 | 20 | $5,911 | $296 |
| Novolog | 11 | $3,408 | $310 |
| Levothyroxine | 94 | $2,713 | $29 |
| Hydrocortisone | 20 | $1,213 | $61 |
| Ultra-Fine Mini Pen Needle | 16 | $1,004 | $63 |
| Methimazole | 38 | $693 | $18 |
| Alendronate | 35 | $593 | $17 |
| Dexamethasone | 11 | $11 | $1 |
2021: 14 drugs
| Forteo | 14 | $62,438 | $4,460 |
| Tymlos | 24 | $54,759 | $2,282 |
| Prolia | 36 | $46,815 | $1,300 |
| Januvia | 17 | $20,111 | $1,183 |
| Basaglar Kwikpen U-100 | 24 | $5,740 | $239 |
| Levothyroxine | 105 | $2,542 | $24 |
| Ultra-Fine Mini Pen Needle | 29 | $1,687 | $58 |
| Hydrocortisone | 15 | $902 | $60 |
| Testosterone Cypionate | 14 | $783 | $56 |
| Methimazole | 35 | $652 | $19 |
| Cabergoline | 14 | $388 | $28 |
| Alendronate | 22 | $225 | $10 |
| Atorvastatin | 11 | $156 | $14 |
| Dexamethasone | 11 | $10 | $1 |
2020: 13 drugs
| Forteo | 36 | $122,699 | $3,408 |
| Prolia | 14 | $16,410 | $1,172 |
| Novolog Flexpen | 20 | $5,887 | $294 |
| Basaglar Kwikpen U-100 | 21 | $5,719 | $272 |
| Lantus Solostar | 11 | $2,446 | $222 |
| Levothyroxine | 86 | $2,386 | $28 |
| Ultra-Fine Mini Pen Needle | 31 | $1,692 | $55 |
| Novolin 70-30 | 11 | $1,572 | $143 |
| Testosterone Cypionate | 13 | $319 | $25 |
| Hydrocortisone | 11 | $308 | $28 |
| Methimazole | 22 | $247 | $11 |
| Alendronate | 32 | $236 | $7 |
| Atorvastatin | 13 | $148 | $11 |
2019: 1 drug
| Levothyroxine | 11 | $320 | $29 |
2014: 1 drug
| Clopidogrel | 14 | $118 | $8 |
Money from drug and device companies
$35 in 2019
A payment is not proof that care is biased.
| Medtronic MiniMed | Minimed 670g System | $35 | 1 payment
|
See the published payment
| Medtronic MiniMed | Meals · 2019-03-01 | Minimed 670g System | $35 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1376987453
- Licence
- CA A162690California A162690: Current · expires 2027-05-31
- Trained
- Vanderbilt University School of Medicine, 2013
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 69 Jesse Hill Jr Dr Se, Suite 209, Atlanta, GA, 30303
- NPI first listed
- 2013-04-19
- NPI last updated
- 2019-07-29
This is when the NPI record was last certified, not a medical board exam.